Is Indivior Pharmaceuticals Inc (INDV) a Buy, Sell, or Hold?
NASDAQ : INDV
Indivior Pharmaceuticals Inc
$38.82 USD
$0.15 (0.39%)
- Volume
- 1.69M
- Average Volume
- 1.98M
- Market Capitalization
- $4.84B
- P/E Ratio
- 13.67
- Dividend Yield
- 0.00%
- Price Target
- $48.00
- Year High
- $42.81
- Year Low
- $21.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.84
Company Overview
NASDAQ
Joseph J. Ciaffoni
Drug Manufacturers - Specialty & Generic
Healthcare
INDV
833
US
USD
Liquidity Metrics
-2.45
0.84
0.66
0.26
0.00
Sales & Valuation
$1.24B
3.64
-23.40
-43.64
-0.89
Profitability
$1.64
$210M
26.65%
29.50%
-216.13%
28.79%
P/E Metrics
13.67
0.07
0.07
Analyst Price Target & Rating
$48.00
$53.00
$43.00
2/5
4 Analysts
-19.13%
Financial Health Scores
3.69
4/9
-$143M
$1.23B
$1.44B
$420M
Key Metrics (TTM)
$5.11B
3.84
11.83
0.84
-216.13%
125.11%
7.32%
-2.30%
282 days
Company Executives
| Name | Title |
|---|---|
| Jeffrey W. Burris | Chief Legal Officer |
| Joseph J. Ciaffoni | Chief Executive Officer & Director |
| Vanessa Procter | Executive Vice President of Corporate Affairs |
| Kevin L. Espinoza | Chief Integrity & Compliance Officer |
| Ryan Preblick | Chief Financial Officer |
| Angela Colon-Mahoney | Chief Human Resources Officer |
| Alice G. Givens | Company Secretary |
| Jason Thompson | Vice President of Investor Relations |
| Christian Heidbreder | Chief Scientific Officer |
| Patrick A. Barry | Chief Commercial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Indivior Pharmaceuticals Inc (NASDAQ:INDV) Stock
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia. ...
2026-08-07 12:00:00
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
2026-08-07 11:21:00
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Supernus Pharmaceuticals, Inc. (NasdaqGM: SUPN) to Indivior Pharmaceuticals, Inc. (Nasdaq: INDV). Under the terms of the proposed transaction, shareholders of Supernus will receive 1.5401 common shares of Indivior for each share of Supernus that they own. KSF is seeking to determine whether this con.
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
2026-08-04 13:21:09
Indivior announces a merger with Supernus to form a CNS-focused biopharma company, tops Q2 earnings and revenue estimates and raises its 2026 outlook.
2026-08-03 16:00:00
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) PR Newsw
2026-08-03 15:15:00
NEW YORK, Aug. 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Indivior Pharmaceuticals, Inc. (NASDAQ: INDV ) related to its merger with Supernus Pharmaceuticals, Inc. Upon closing of the proposed transaction, Indivior shareholders will own approximately 56.5% of the combined company.
Supernus Pharmaceuticals (SUPN) Announces Transformative Merger with Indivior (INDV)
2026-08-03 12:14:00
Supernus Pharmaceuticals (SUPN) has seen its stock rise following the announcement of an all-stock merger with Indivior (INDV). This strategic move comes alongs
2026-08-03 10:44:26
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals Inc. (NASDAQ:INDV) on Monday agreed to unite through a tax-free all-stock merger of equals, forming a central nervous system (CNS) biopharmaceutical company.
2026-08-03 10:44:00
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) and Supernus Pharmaceuticals, Inc. Upon closing of the Proposed Transaction, Indivior shareholders will own approximately 56.5% of the combined company.Halper Sadeh encourages Indivior shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersa.
Frequently Asked Questions
-
What is the current Indivior Pharmaceuticals Inc (INDV) stock price?
-
Indivior Pharmaceuticals Inc(NASDAQ:INDV) stock price is $38.82 in the last trading session. During the trading session, INDV stock reached the peak price of $42.81 while $21.83 was the lowest point it dropped to. The percentage change in INDV stock occurred in the recent session was 0.39% while the dollar amount for the price change in INDV stock was $0.15.
-
INDV's industry and sector of operation?
-
The NASDAQ listed INDV is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of INDV?
-
Jeffrey W. Burris | Chief Legal Officer
Joseph J. Ciaffoni | Chief Executive Officer & Director
Vanessa Procter | Executive Vice President of Corporate Affairs
Kevin L. Espinoza | Chief Integrity & Compliance Officer
Ryan Preblick | Chief Financial Officer -
How many employees does INDV have?
-
Number of INDV employees currently stands at 833. INDV operates from 10710 Midlothian Turnpike, North Chesterfield, VA 23235, US.
-
Link for INDV official website?
-
Official Website of INDV is: https://www.indivior.com
-
How do I contact INDV?
-
INDV could be contacted at phone #804 379 1090 and can also be accessed through its website. INDV operates from 10710 Midlothian Turnpike, North Chesterfield, VA 23235, US.
-
How many shares of INDV are traded daily?
-
The average number of INDV shares traded daily for last 3 months was 1.98M.
-
What is the market cap of INDV currently?
-
The market value of INDV currently stands at $4.84B with its latest stock price at $38.82